Abstract
Characteristics and Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Receiving Venetoclax Combinations Vs Other Therapies: Results from the AML Real World Evidence (ARC) Initiative
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have